First of its kind study to investigate the effects of Almond Therapy in TRD patients receiving intranasal esketamine.
Zylorion Receives Approval for Phase II Clinical Study for its Proprietary Almond TherapyTM
View More
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.